Preparation method of recombination human thymosin beta 16
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- FILLDERM (CHANGCHUN) MEDICINE BIOLOGY TECH CO LTD
- Publication Date
- 2009-12-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention belongs to the field of biological engineering. Background technique:
[0002] Thymosin is a general term for a family of polypeptides that widely exist in humans and animals. These small molecular polypeptides are composed of 40-45 amino acids, and the sequences among family members are highly conserved. Most of them have a molecular weight of about 5kDa, and they are a kind of polar polypeptide molecules.
[0003] Thymosin can be divided into α-type, β-type and γ-type according to the isoelectric point difference of family members. Among them, due to their important roles in various physiological and biochemical processes, the functions and mechanisms of β-type family members have gradually become one of the research hotspots in recent years. Thymosin β4 chemically synthesized abroad has entered phase II clinical application in corneal repair, skin burns, and ulcer repair. However, the chemical synthesis method is costly and easy to...